Patents by Inventor Alexzander Asea

Alexzander Asea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VITAMIN D3, HEAT SHOCK PROTEINS, AND GLUTATHIONE FOR THE TREATMENT OF CHRONIC INFLAMMATION AND CHRONIC DISEASES
    Publication number: 20200009161
    Abstract: The present disclosure is directed to co-administration of high dose Vitamin D3, heat shock proteins, glutathione, and kits provided for co-administration of these compositions, for the treatment of patients with chronic inflammation and chronic diseases.
    Type: Application
    Filed: September 23, 2019
    Publication date: January 9, 2020
    Inventors: Leslie Ray Matthews, Alexzander Asea
  • Vitamin D, heat shock proteins, and glutathione for the treatment of chronic inflammation and chronic diseases
    Patent number: 10500217
    Abstract: The present disclosure is directed to co-administration of high dose Vitamin D3, heat shock proteins, glutathione, and kits provided for co-administration of these compositions, for the treatment of patients with chronic inflammation and chronic diseases.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: December 10, 2019
    Assignee: LESLIE RAY MATTHEWS, M.D., LLC
    Inventors: Leslie Ray Matthews, Alexzander Asea
  • VITAMIN D3, HEAT SHOCK PROTEINS, AND GLUTATHIONE FOR THE TREATMENT OF CHRONIC INFLAMMATION AND CHRONIC DISEASES
    Publication number: 20190328754
    Abstract: The present disclosure is directed to co-administration of high dose Vitamin D3, heat shock proteins, glutathione, and kits provided for co-administration of these compositions, for the treatment of patients with chronic inflammation and chronic diseases.
    Type: Application
    Filed: April 30, 2018
    Publication date: October 31, 2019
    Inventors: Leslie Ray Matthews, Alexzander Asea
  • COMPOSITIONS AND METHODS FOR TREATMENT OF METASTATIC CANCER
    Publication number: 20140351961
    Abstract: Disclosed are methods and compositions for treating cancer that involved an isolated double stranded ribonucleic acid (dsRNA) molecule that inhibits the expression of Hsp-27.
    Type: Application
    Filed: August 30, 2012
    Publication date: November 27, 2014
    Inventor: Alexzander A. Asea
  • Methods and compositions for post-transcriptional gene silencing
    Publication number: 20100186102
    Abstract: An isolated double stranded ribonucleic acid (dsRNA) molecule that inhibits the expression of a target gene, the dsRNA comprising two strands of nucleotides wherein a first strand has a length of from 19 to 28 consecutive nucleotides and is substantially identical to a sequence in the target gene and wherein a second strand is substantially complementary to the first strand, and a binding moiety that binds a 3? end of the first strand to a 5? end of the second strand. An isolated double stranded ribonucleic acid molecule comprising a first strand of nucleotides that is substantially identical to SEQ ID NO: 3 and a second strand that is substantially complementary to the first.
    Type: Application
    Filed: August 21, 2008
    Publication date: July 22, 2010
    Applicant: Scott and White Memorial Hospital and Scott, Sherwood, and Brindley Foundation
    Inventor: Alexzander Asea